Elevance Health Inc. (ELV) Tops Q3 EPS by $2.29, Beats on Revenue; Offers FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mailGet Alerts ELV Hot Sheet
Join SI Premium – FREE
Elevance Health Inc. (NYSE: ELV) reported Q3 EPS of $6.99, $2.29 better than the analyst estimate of $4.70. Revenue for the quarter came in at $50.4 billion versus the consensus estimate of $49.32 billion.
GUIDANCE:
Elevance Health Inc. sees FY2026 EPS of $29.00, versus the consensus of $27.24.
For earnings history and earnings-related data on Elevance Health Inc. (ELV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- First Bancorp (FNLC) Tops Q3 EPS by 95c
- Old Second Bancorp (OSBC) Misses Q3 EPS by 2c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
